Analyst picks & changes

Amgen Inc.

(AMGN)

Cephalon Inc.

(CEPH)

Chiron Corp.

(CHIR)

CytoTherapeutics Inc.

(CTII)

Regeneron Pharmaceuticals Inc.

(REGN)

Rhone-Poulenc Rorer

SmithBarney analyst Toni Claudio surveyed recent clinical trials of compounds to treat amyotrophic lateral sclerosis. She concluded that RPR's

Rilutek

,

Read the full 383 word article

How to gain access

Continue reading with a
two-week free trial.